WCG CenterWatch iConnect Selected for The Michael J. Fox Foundation’s Fox Trial Finder
WCG has announced that The Michael J. Fox Foundation for Parkinson’s Research is introducing a redesigned version of its Fox Trial Finder clinical study matching tool powered by WCG CenterWatch iConnect. The platform provides advanced trial listing technology for patient advocacy groups, and also allows sponsors to set up and manage all aspects of their patient recruitment.
For more information, click here.
Key Phase 3 Trial Results Lead to FDA Approval of Fabhalta for Paroxysmal Nocturnal Hemoglobinuria
December 6th 2023Clinical trials demonstrated superiority of Fabhalta to anti-C5s in hemoglobin improvement in the absence of transfusions and transfusion avoidance rate, showing clinically meaningful hemoglobin-level increases without the need for blood transfusions in patients with paroxysmal nocturnal hemoglobinuria.
‘Hypothesis-Free’: Getting Proactive About Signal Detection
December 5th 2023Elizabeth Smalley, director of product management, data, and analytics at ArisGlobal speaks about her work at the software company in supporting the efforts of life sciences clinical and pharmacovigilance teams in signal detection.
